A federal judge dismissed a lawsuit that sought to block a California law requiring drug makers to not only provide advance notice of price hikes, but also give the reasons for any increases.

In explaining his decision, U.S. District Judge Morrison England Jr. ruled that the Pharmaceutical Research and Manufacturers of America failed to show that the court has jurisdiction to hear the case. However, he wrote that the trade group can refile its case if it can prove that any potential harm to drug makers falls “outside the realm of conjecture,” a step that would give PhRMA standing to press it case.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy